Translational gastroenterology and hepatology
Erratum: The effective molecular characteristics of PD-1 inhibitor combination regimen as the first-line treatment for Chinese patients with HER2-positive gastric cancer: a real-world retrospective analysis study.
Editorial Office
Published: 202510.21037/tgh-20251-01
Abstract
Open Access[This corrects the article DOI: 10.21037/tgh-24-95.].